Treatment:
angiotensin_2 S435-p
anti-CD3 S156-p
AZD1152 S161-p , S224-p
BI2536 S156-p , S161-p , S224-p , T229-p , S300-p , S477-p
BI_4834 S300-p
EGF T358-p
gefitinib S500-p , S519-p
ischemia S280-p , S300-p , S345-p , S384-p , S660-p
lapatinib S202-p , S435-p
metastatic potential S356-p , S357-p , T358-p , S435-p
MLN8054 S156-p , S300-p , S477-p
nocodazole S300-p
SB202190 S339-p , S345-p
selumetinib S496-p
SII_angiotensin_2 S156-p
Y27632 S234-p
ZM447439 S161-p , S224-p